Product logins

Find logins to all Clarivate products below.


Emerging Vaccines – Epidemiology – Vaccines Epidemiology Forecaster

The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.

QUESTIONS ANSWERED

  • What is the addressable market for vaccines in development, and how will that change over time?
  • What is the current coverage of a vaccine in a specific country?
  • What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?

GEOGRAPHIES

  • Global, with additional granularity for the G7

EPIDEMIOLOGY

  • Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.

COVERAGE

  • Vaccine coverage includes: BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever

DATA & FEATURES

  • Delivered as a stand-alone Excel model based on DRG’s gold-standard epidemiology for vaccine coverage.
  • G7 dashboard facilitates a more-granular analysis in the mature markets.
  • Options to incorporate additional primary or secondary data and customizable deliverables.
  • Access to DRG’s expert epidemiologists for bespoke support.

Related Market Assessment Reports

Report
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of CIDP comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy,…
Report
Diabetic Neuropathy – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of diabetic…
Report
Diabetic Neuropathy – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
Report
Diabetic Neuropathy – Epidemiology – Extrapolated Worldwide Coverage
Clarivate Epidemiology’s coverage of diabetic neuropathy comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the total prevalence of diabetic…
Report
Inflammatory Myositis – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of inflammatory myositis (IM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…